Earnings Feed
Start Free
Home/Filings/4/0001225208-25-004799
4//SEC Filing

Zovighian Bernard J 4

Accession 0001225208-25-004799

CIK 0001099800other
View on SEC.govCompany Profile

Filed

May 5, 8:00 PM ET

Accepted

May 6, 5:13 PM ET

Size

18.5 KB

Accession

0001225208-25-004799

Insider Transaction Report

Form 4
Period: 2025-05-03
Edwards Lifesciences CorpEW
Zovighian Bernard J
DirectorCEO
Transactions
  • Exercise/Conversion

    Common Stock

    2025-05-05$45.28/sh+7,462$337,855→ 65,745.551 total
  • Gift

    Common Stock

    2025-05-06−1,036→ 57,247.551 total
  • Gift

    Common Stock

    2025-05-05+1,482→ 11,918 total(indirect: By Trust)
  • Gift

    Common Stock

    2025-05-06+1,036→ 12,954 total(indirect: By Trust)
  • Tax Payment

    Common Stock

    2025-05-04$75.65/sh−543$41,078→ 58,283.551 total
  • Gift

    Common Stock

    2025-05-05−1,482→ 64,263.551 total
  • Sale

    Common Stock

    2025-05-05$74.91/sh−5,980$447,977→ 58,283.551 total
  • Tax Payment

    Common Stock

    2025-05-03$75.65/sh−527$39,868→ 58,826.551 total
  • Exercise/Conversion

    Employee Stock Option (Right to Acquire)

    2025-05-05−7,462→ 0 total
    Exercise: $45.28Exp: 2025-05-16→ Common Stock (7,462 underlying)
Holdings

  • Common Stock

    (indirect: By 401(k))
    3,605.849
Footnotes (3)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024.
  • [F2]This transaction was executed in multiple trades at prices ranging from $74.67 to $75.15 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]These options were granted on May 17, 2018 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one yearafter the grant date in four equal annual installments.

Documents

1 file

Issuer

Edwards Lifesciences Corp

CIK 0001099800

→
Entity typeother

Related Parties

1
  • filerCIK 0001665141

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 5:13 PM ET
Size
18.5 KB
View on SEC.gov